Cochrane Abstracts
Rituximab for eradicating inhibitors in people with acquired haemophilia A
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab for Eradicating Inhibitors in People With Acquired Haemophilia A." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439908/all/Rituximab_for_eradicating_inhibitors_in_people_with_acquired_haemophilia_A.
Rituximab for eradicating inhibitors in people with acquired haemophilia A. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439908/all/Rituximab_for_eradicating_inhibitors_in_people_with_acquired_haemophilia_A. Accessed March 26, 2025.
Rituximab for eradicating inhibitors in people with acquired haemophilia A. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439908/all/Rituximab_for_eradicating_inhibitors_in_people_with_acquired_haemophilia_A
Rituximab for Eradicating Inhibitors in People With Acquired Haemophilia A [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439908/all/Rituximab_for_eradicating_inhibitors_in_people_with_acquired_haemophilia_A.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab for eradicating inhibitors in people with acquired haemophilia A
ID - 439908
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439908/all/Rituximab_for_eradicating_inhibitors_in_people_with_acquired_haemophilia_A
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
